Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,54 USD | +12,89% | +20,67% | +3,25% |
27/03 | BIOATLA, INC. : HC Wainwright mantiene la raccomandazione Buy | ZM |
26/03 | Transcript : BioAtla, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Attività
Numero di dipendenti: 65
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jay Short
CEO | Chief Executive Officer | 66 | 01/03/07 |
Founder | 59 | 01/03/07 | |
Richard Waldron
DFI | Director of Finance/CFO | 70 | 01/01/11 |
Gerhard Frey
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/07 |
Cathy Chang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eric Sievers
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/06/19 |
Scott Smith
BRD | Director/Board Member | 61 | 10/09/18 |
Susie Melody
HRO | Human Resources Officer | - | - |
Comptroller/Controller/Auditor | 48 | 01/11/15 | |
Mike Melnick
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 01/12/20 |
Jay Short
CEO | Chief Executive Officer | 66 | 01/03/07 |
Director/Board Member | 76 | 01/01/16 | |
Edward Williams
BRD | Director/Board Member | 68 | 16/12/21 |
Sylvia Mcbrinn
BRD | Director/Board Member | 71 | 15/06/21 |
Scott Smith
BRD | Director/Board Member | 61 | 10/09/18 |
Susan Moran
BRD | Director/Board Member | 54 | 01/12/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 48 096 717 | 43 366 546 ( 90,17 %) | 0 | 90,17 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+3,25% | 122 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione BCAB
- Società BioAtla, Inc.